Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRD1 | P41143 | 1/20 | 0.54 |
| ▸ | BACE1 | P56817 | 8/20 | 0.54 |
| ▸ | MME | P08473 | 4/20 | 0.53 |
| ▸ | ACE | P12821 | 3/20 | 0.53 |
| ▸ | CPA1 | P15085 | 1/20 | 0.53 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.53 |
| ▸ | BACE2 | Q9Y5Z0 | 2/20 | 0.51 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.51 |
| ▸ | CASP1 | P29466 | 1/20 | 0.50 |
| ▸ | CASP3 | P42574 | 1/20 | 0.49 |
| ▸ | CASP7 | P55210 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30445563 | 1.00 | OPRD1 (0.54) | OPRD1BACE1MMEACECPA1 | |
| SCHEMBL217352 | 0.91 | FOLH1 (0.60) | OPRD1BACE1MMEACECPA1 | |
| SCHEMBL17305518 | 0.91 | BACE1 (0.62) | BACE1BACE2 | |
| SCHEMBL31206305 | 0.91 | BACE1 (0.62) | BACE1BACE2 | |
| SCHEMBL29665022 | 0.90 | NAALAD2 (0.57) | MMEACECPA1ACE2FOLH1 | |
| SCHEMBL7935661 | 0.90 | NAALAD2 (0.57) | MMEACECPA1ACE2FOLH1 | |
| SCHEMBL30641532 | 0.90 | NPY1R (0.54) | OPRD1BACE1BACE2 | |
| SCHEMBL30445509 | 0.89 | MME (0.54) | OPRD1MMEACECPA1ACE2 | |
| SCHEMBL31062503 | 0.89 | OPRD1 (0.61) | OPRD1BACE1BACE2CASP3CASP7 | |
| SCHEMBL30331349 | 0.89 | OPRD1 (0.56) | OPRD1BACE1MMEBACE2CASP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4573103-A1 | COMPOUNDS USEFUL FOR THE TREATMENT AND/OR CARE OF THE SKIN, HAIR, NAILS AND/OR MUCOUS MEMBRANES | Lubrizol Advanced Materials, Inc. (US) | 2025-06-25 | — | — | EP | disclosed |
| CN-119569818-A | Liquid phase preparation method of thymic pentapeptide | 恒敬合创生物医药（浙江）有限公司 | 2025-03-07 | — | — | CN | disclosed |
| EP-4316460-A1 | COSMETIC COMPOSITIONS COMPRISING A SYNERGIC MIX OF ACTIVE INGREDIENTS HAVING ANTIAGING ACTIVITY | Unifarco S.p.A. (IT) | 2024-02-07 | — | — | EP | disclosed |
| EP-4192843-A1 | PEPTIDES ABLE TO BIND ANGIOTENSIN-CONVERTING ENZYME 2 (ACE2) AND MEDICAL USES THEREOF | Ospedale Pediatrico Bambino Gesù (IT) | 2023-06-14 | — | — | EP | disclosed |